RHUMBLINE ADVISERS - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 438 filers reported holding REPLIGEN CORP in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$25,463,497
+11.0%
160,138
-1.3%
0.03%
+15.4%
Q2 2023$22,940,568
+85861.6%
162,170
+2.3%
0.03%
-21.2%
Q1 2023$26,687
+1.7%
158,510
+2.3%
0.03%
-5.7%
Q4 2022$26,229
-99.9%
154,917
+2.2%
0.04%
-16.7%
Q3 2022$28,354,000
+17.6%
151,537
+2.1%
0.04%
+20.0%
Q2 2022$24,115,000
-7.7%
148,492
+7.0%
0.04%
+2.9%
Q1 2022$26,113,000
-29.1%
138,830
-0.2%
0.03%
-24.4%
Q4 2021$36,856,000
-5.8%
139,162
+2.8%
0.04%
-15.1%
Q3 2021$39,121,000
+43.9%
135,370
-0.6%
0.05%
+47.2%
Q2 2021$27,179,000
+1.0%
136,154
-1.6%
0.04%
-2.7%
Q1 2021$26,901,000
+1.3%
138,375
-0.1%
0.04%0.0%
Q4 2020$26,554,000
+29.1%
138,570
-0.6%
0.04%
+15.6%
Q3 2020$20,573,000
+18.1%
139,439
-1.0%
0.03%
+10.3%
Q2 2020$17,413,000
+16.3%
140,871
-9.1%
0.03%
-6.5%
Q1 2020$14,967,000
+2.6%
155,035
-1.7%
0.03%
+29.2%
Q4 2019$14,582,000
+24.1%
157,648
+2.9%
0.02%
+14.3%
Q3 2019$11,749,000
+0.0%
153,202
+12.1%
0.02%
-4.5%
Q2 2019$11,747,000
+53.6%
136,671
+5.6%
0.02%
+46.7%
Q1 2019$7,650,000
+13.0%
129,477
+0.9%
0.02%0.0%
Q4 2018$6,767,000
+10.8%
128,308
+16.5%
0.02%
+25.0%
Q3 2018$6,110,000
+17.8%
110,176
-0.1%
0.01%
+20.0%
Q2 2018$5,186,000
+35.8%
110,250
+4.4%
0.01%
+25.0%
Q1 2018$3,820,000
+2.5%
105,594
+2.8%
0.01%0.0%
Q4 2017$3,727,000
+9.1%
102,734
+15.3%
0.01%
+14.3%
Q3 2017$3,415,000
-1.6%
89,120
+6.4%
0.01%
-12.5%
Q2 2017$3,472,000
+17.5%
83,783
-0.2%
0.01%
+14.3%
Q1 2017$2,956,000
+47.7%
83,987
+29.3%
0.01%
+40.0%
Q4 2016$2,001,000
+5.5%
64,941
+3.4%
0.01%0.0%
Q3 2016$1,896,000
+15.0%
62,801
+4.2%
0.01%0.0%
Q2 2016$1,649,000
+5.4%
60,271
+3.3%
0.01%0.0%
Q1 2016$1,565,000
-4.0%
58,339
+1.2%
0.01%0.0%
Q4 2015$1,630,000
+11.2%
57,619
+9.4%
0.01%0.0%
Q3 2015$1,466,000
-30.6%
52,649
+2.9%
0.01%
-28.6%
Q2 2015$2,111,000
+32.4%
51,146
-2.6%
0.01%
+40.0%
Q1 2015$1,595,000
+69.5%
52,521
+10.5%
0.01%
+66.7%
Q4 2014$941,000
-2.0%
47,546
-1.3%
0.00%0.0%
Q3 2014$960,000
-12.7%
48,196
-0.2%
0.00%0.0%
Q2 2014$1,100,000
+93.0%
48,271
+8.8%
0.00%
+50.0%
Q1 2014$570,000
-8.9%
44,353
-3.3%
0.00%0.0%
Q4 2013$626,000
+26.2%
45,883
+2.7%
0.00%0.0%
Q3 2013$496,000
+112.9%
44,683
+58.0%
0.00%
+100.0%
Q2 2013$233,00028,2880.00%
Other shareholders
REPLIGEN CORP shareholders Q4 2022
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders